Standard Glass Lining IPO

Standard Glass Lining IPO opens for subscription on January 6, 2025 and closes on January 8, 2025. The allotment for the Standard Glass Lining IPO is expected to be finalized on Thursday, January 9, 2025. Standard Glass Lining IPO will list on BSE, NSE with tentative listing date fixed as Monday, January 13, 2025.

Standard Glass Lining IPO price band is set at ₹133 to ₹140 per share. The minimum lot size for an application is 107. The minimum amount of investment required by retail investors is ₹14,980. The minimum lot size investment for sNII is 14 lots (1,498 shares), amounting to ₹2,09,720, and for bNII, it is 67 lots (7,169 shares), amounting to ₹10,03,660.

Standard Glass Lining IPO is a book built issue of Rs 410.05 crores. The issue is a combination of fresh issue of 1.50 crore shares aggregating to Rs 210.00 crores and offer for sale of 1.43 crore shares aggregating to Rs 200.05 crores.

Standard Glass Lining IPO Details

Standard Glass Lining IPO Lot Size

Investors can bid for a minimum of 107 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Standard Glass Lining IPO Objectives

The Company proposes to utilize the Net Proceeds towards funding the following objects:

• Funding of capital expenditure requirements of the Company towards the purchase of machinery and equipment;
• Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company and investment in the wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by S2 Engineering Industry Private Limited, from banks and financial institutions;
• Investment in the wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for funding its capital expenditure requirements towards purchase of machinery and equipment;
• Funding inorganic growth through strategic investments and/or acquisitions and
• General corporate purposes

About Standard Glass Lining Technology

Incorporated in September 2012, Standard Glass Lining Technology is a manufacturer of engineering equipment for the pharmaceutical and chemical sectors in India. The company has the capability to manage the entire production process in-house.

The company provides turnkey solutions, including design, engineering, manufacturing, assembly, installation, and standard operating procedures for pharmaceutical and chemical manufacturers.

The company’s product product portfolio includes

• Reaction Systems;
• Storage, Separation and Drying Systems; and
• Plant, Engineering and Services

The company manufactures specialized engineering equipment using glass-lined materials, stainless steel, and nickel alloy.

The company’s customer includes Apitoria Pharma Private Limited, Aurobindo Pharma Limited, CCL Food and Beverages Private Limited, Cohance Lifesciences Limited, Cadila Pharmaceutical Limited, Deccan Fine Chemicals (India) Private Limited, Dasami Lab Private Limited, Laurus Labs Limited, Granules India Limited, Macleods Pharmaceuticals Limited, MSN Laboratories Private Limited, Natco Pharma Limited, Honour Lab Limited, Hetero Drugs Limited, Hetero Labs Limited, Hazelo Lab Private Limited, Piramal Pharma Limited, Sanvira Biosciences Private Limited, Suven Pharmaceuticals Limited, Tagros Chemicals India Private Limited, Vamsi Labs Limited and Viyash Life Sciences Private Limited.

The company has eight manufacturing units situated in Hyderabad, Telangana.

The company’s sales offices are situated in Vadodara, Gujarat, Ankleshwar, Gujarat, Mumbai, Maharashtra and Vishakhapatnam, Andhra Pradesh and sales team members are in Jhagadia, Gujarat, Chennai, Tamil Nadu, New Delhi, Bengaluru, Karnataka and Vijayawada, Andhra Pradesh with pan-India reach.

As of September 30, 2024, the company had 460 full-time employees and 731 contract labourers.

Competitive Strength

1. Specialised engineering equipment manufacturers for the pharmaceutical and chemical sectors.
2. Customized and innovative range of products throughout the entire pharmaceutical and chemical manufacturing value chain.
3. Strategically located manufacturing facilities with advanced technological capabilities.
4. Long term relationships with marquee clientele across sectors.
5. Consistent track record of profitable growth.

Standard Glass Lining Technology Financial Information

Standard Glass Lining IPO Reservation

Standard Glass Lining IPO Timeline (Tentative Schedule)

Standard Glass Lining IPO opens on January 6, 2025, and closes on January 8, 2025.